BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 15797757)

  • 21. Predictive Model for Secundum Atrial Septal Defect Closure with Pulmonary Artery Hypertension in Adult: When to Close.
    Supomo S; Arjana AZ; Darmawan H
    Heart Surg Forum; 2018 Mar; 21(2):E108-E111. PubMed ID: 29658869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous therapy with intravenous prostacyclin for primary pulmonary hypertension: a bridge to heart-lung transplantation.
    Kramer MR; Fucks S; Simon Z; Berkman N
    Isr J Med Sci; 1993 Oct; 29(10):613-6. PubMed ID: 8244657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moderate-term effect of epoprostenol on severe portopulmonary hypertension.
    Kato H; Katori T; Nakamura Y; Kawarasaki H
    Pediatr Cardiol; 2003; 24(1):50-3. PubMed ID: 12574979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical closure of atrial septal defect in patients older than 30 years: risk factors for late death from arrhythmia or heart failure.
    Hörer J; Müller S; Schreiber C; Kostolny M; Cleuziou J; Prodan Z; Holper K; Lange R
    Thorac Cardiovasc Surg; 2007 Mar; 55(2):79-83. PubMed ID: 17377858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertensive pulmonary vascular disease in adults with secundum or sinus venosus atrial septal defect.
    Sachweh JS; Daebritz SH; Hermanns B; Fausten B; Jockenhoevel S; Handt S; Messmer BJ
    Ann Thorac Surg; 2006 Jan; 81(1):207-13. PubMed ID: 16368366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prostacyclin oral internal therapy for severe pulmonary hypertension after total correction of cor triatriatum with partial anomalous pulmonary venous return; report of a case].
    Hamawaki M; Tomino T; Sato H; Imura M; Suzuki K; Nakashima K; Okamoto Y
    Kyobu Geka; 2004 Feb; 57(2):147-50. PubMed ID: 14978912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The fate of the pulmonary hypertension after ASD-closure in adults (author's transl)].
    Reichart B; Brunner L; Beyer J; Kreuzer E; Sunder-Plassmann L; Theissen K; Krötz J; Müller-Seydlitz P
    Thoraxchir Vask Chir; 1975 Oct; 23(5):447-51. PubMed ID: 1081764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repaired and open atrial septal defects type II in adulthood: an epidemiological study of a large European cohort.
    Engelfriet P; Meijboom F; Boersma E; Tijssen J; Mulder B
    Int J Cardiol; 2008 Jun; 126(3):379-85. PubMed ID: 17586067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Severe pulmonary hypertension in ostium secundum atrial septal defect].
    Boussaada R; Fajraoui MH; Cherif A; Mechmeche R
    Tunis Med; 2001 Dec; 79(12):662-7. PubMed ID: 11892439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.
    Aguilar RV; Farber HW
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1846-50. PubMed ID: 11069824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of single- and double-patch techniques for sinus venosus atrial septal defect with partial anomalous pulmonary venous connection.
    Iyer AP; Somanrema K; Pathak S; Manjunath PY; Pradhan S; Krishnan S
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):656-9. PubMed ID: 17320561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The successful management of severe protamine-induced pulmonary hypertension using inhaled prostacyclin.
    Jerath A; Srinivas C; Vegas A; Brister S
    Anesth Analg; 2010 Feb; 110(2):365-9. PubMed ID: 19933533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secundum atrial septal defect and pulmonary hypertension in an 86-year-old woman: a case report and review of the literature.
    Tozzini S; Anichini C; Nesi G; Pedemonte E; Gori F
    Ital Heart J; 2002 Nov; 3(11):682-5. PubMed ID: 12506528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertrophic cardiomyopathy complicated by atrial septal defect and pulmonary hypertension.
    Lim DS; Bergin JD; Ragosta M
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):659-64. PubMed ID: 18360863
    [No Abstract]   [Full Text] [Related]  

  • 35. [Feasibility of cardiopulmonary rehabilitation in patients with idiopathic pulmonary arterial hypertension treated with intravenous prostacyclin infusion therapy].
    Uchi M; Saji T; Harada T
    J Cardiol; 2005 Nov; 46(5):183-93. PubMed ID: 16320975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Look before you close: atrial septal defect with undiagnosed partial anomalous pulmonary venous return.
    Cragun DT; Lax D; Butman SM
    Catheter Cardiovasc Interv; 2005 Nov; 66(3):432-5. PubMed ID: 16208710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial septal defect in adults: the influence of age and haemodynamic parameters on the results of surgical repair.
    Suchoń E; Tracz W; Podolec P; Sadowski J
    Kardiol Pol; 2006 May; 64(5):470-6; discussion 477-8. PubMed ID: 16752329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease.
    Thomas IC; Glassner-Kolmin C; Gomberg-Maitland M
    Int J Cardiol; 2013 Oct; 168(4):4117-21. PubMed ID: 23890862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels.
    Chin KM; Channick RN; Kim NH; Rubin LJ
    Chest; 2007 Sep; 132(3):786-92. PubMed ID: 17646224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension.
    Schenk P; Petkov V; Madl C; Kramer L; Kneussl M; Ziesche R; Lang I
    Chest; 2001 Jan; 119(1):296-300. PubMed ID: 11157622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.